Search for: "ABBOTT v. ABBOTT"
Results 1801 - 1820
of 2,570
Sorted by Relevance
|
Sort by Date
1 Jul 2011, 2:00 am
Abbott and many amici, including AIPLA & ABA say yes. [read post]
5 Oct 2011, 3:44 am
General Nagoya Protocol on biodiversity benefit-sharing has 64 signatories (IP Watch) Book review Monday: Development and Health in Poor Countries (Patent Baristas) EU: OHIM Boards of Appeal: pharmaceutical products and cosmetics: Case R 877/2010-2 (Class 46) India: Conducting a post-mortem on Astella’s Indian patent no: 234753 (Spicy IP) India: Delhi High Court passes ex-parte interim injunction against Symed Labs for alleged infringement of Indian Patent No: 221536: Vifor v… [read post]
5 Jan 2010, 3:41 am
"greta thinks she knows why her plastic surgery was such a big deal" http://j.mp/6cXsv7 @GrahamY on tony abbott v kevin rudd ... [read post]
27 Mar 2018, 7:20 am
In a majority opinion in Evenwel v. [read post]
1 Jul 2011, 2:00 am
Abbott and many amici, including AIPLA & ABA say yes. [read post]
27 Apr 2011, 4:55 am
(IP Watch) China: Pfizer starts R&D in China after IPR in China challenges (IP Dragon) UK: IPO inviting comment on C-630/10 University of Queensland, CSL Ltd v Comptroller-General of Patents, Designs and Trade Marks and C-130/11 Neurim v Comptroller General of Patents (The SPC Blog) (The SPC Blog) US: New generics quickly grab 80% of sales volume (GenericsWeb) Products Actos (Pioglitazone) – US: Takeda agrees to dismiss one Actos infringement suit against Apotex (Patent… [read post]
8 Mar 2021, 4:00 am
… Doorey’s Workplace Law BlogKovintharajah v. [read post]
21 Mar 2013, 7:55 pm
AIA Cited by CAFC as Remedying Known Patent Reexamination Deficiency As predicted based upon the earlier oral argument, the Federal Circuit closed the door on the potential for discovery in inter partes patent reexamination in Abbott Laboratories v. [read post]
20 Apr 2015, 6:47 am
Abbott, 647 F.3d 202 (5th Cir.2011). [read post]
26 May 2015, 8:31 am
Abbott in its Tuesday case orders. [read post]
30 Dec 2009, 2:00 am
(EPLAW) Thrombin JM - Pharma company avoids injunction by dropping competitive keyword ads: King v ZymoGenetics (Technology & Marketing Law Blog) Vytorin (Ezetimibe, Simvastatin) - US: Schering files patent infringement complaint against Mylan following Para IV challenge (Patent Docs) Xeloda (Capecitabine) - US: Hoffmann-La Roche files patent infringement complaint against Roxane following Para IV challenge (Patent Docs) [read post]
5 Oct 2011, 3:44 am
General Nagoya Protocol on biodiversity benefit-sharing has 64 signatories (IP Watch) Book review Monday: Development and Health in Poor Countries (Patent Baristas) EU: OHIM Boards of Appeal: pharmaceutical products and cosmetics: Case R 877/2010-2 (Class 46) India: Conducting a post-mortem on Astella’s Indian patent no: 234753 (Spicy IP) India: Delhi High Court passes ex-parte interim injunction against Symed Labs for alleged infringement of Indian Patent No: 221536: Vifor v… [read post]
16 Feb 2018, 3:18 am
In a majority opinion in Evenwel v. [read post]
14 May 2010, 11:27 am
Cir. 2005); Abbott Labs. v. [read post]
22 Dec 2010, 10:18 am
See Abbott Labs. v. [read post]
4 Nov 2011, 1:44 pm
Federal Sentencing—Mandatory Minimums Abbott v. [read post]
8 Dec 2023, 7:58 am
Abbott, 2011, and AbbVie v. [read post]
15 Apr 2010, 2:57 pm
Abbott Labs, 201 F.3d 883 (7th Cir. 2000). [read post]
18 Apr 2011, 5:10 pm
Central Time, the Texas Supreme Court will hear oral arguments in Severance v. [read post]
3 Nov 2010, 1:21 am
Pharmachemie (EPLAW) US: Supreme Court to hear Bayh-Dole patent ownership dispute: Stanford v Roche (Patently-O) (IPKat) (IPBiz) US: DoJ amicus brief in Myriad says no to patentability of genomic DNA: AMP v USPTO (IPBiz) (Inventive Step) (Patently-O) (Patent Docs) (Holman’s Biotech IP Blog) US: Briefing update: AMP v USPTO (Patent Docs) US: BIO and AUTM file amicus brief in Myriad case (PatentlyBIOtech) US: Myriad files appeal brief in AMP v USPTO (Patent… [read post]
